Stansberry Research

Dear Stansberry Digest Reader,

I noticed you aren't signed up for tonight's live event… and I'm not sure why.

Maybe you're not interested in the breakthrough that could treat 1 in 2 cancer patients… or the little-known company behind it.

Or maybe you have something else lined up for tonight.

Either way, I think you're making a huge mistake by sitting this one out.

It could easily cost you $400,000 to learn what Dave Lashmet's going to tell you about tonight at 8 p.m. Eastern time – and you'd need to spend a year traveling the world to even try to figure it all out.

Frankly, nobody else can do what Dave does in the technology sector.

As Porter Stansberry said about Dave Lashmet in his annual report card…

"Over the course of Dave's career, his research has identified more than a dozen companies whose groundbreaking technology eventually drove their share prices up 10-times or more."

He added, "In my entire career, I've never seen anything like it."

And tonight, you get to hear from Dave himself for the first time ever.

Because of the small, speculative nature of Dave's Venture Technology most readers never hear from one of our most brilliant analysts.

But tonight at 8 p.m. Eastern time, that's all changing.

To see what Dave will cover in his FREE landmark presentation and to add your name to the guest list, click here.

I strongly encourage you to tune in.

Regards,

Justin Brill
Editor, The Stansberry Digest

P.S. By the way, here's more info on what he's recommending now.